Breast Cancer Trial, Recruiting (NCT06658080)

Breast Cancer Trial, Recruiting NCT06658080 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06658080 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have given written agreement to take part in the study and are willing to participate.
People who are between 18 and 70 years old.
People who have been diagnosed with breast cancer that has spread (metastatic), and who also have fluid build-up in the chest or abdomen that has been confirmed by a lab test to contain cancer cells.
People who are generally well enough to carry out daily activities, based on a standard health scoring system (a score of 0 or 1 on the ECOG scale — confirm with trial site if unsure what this means).
People whose liver and kidney function blood test results are within an acceptable range, meaning no significant problems with these organs (specific blood marker levels must meet set limits — the trial site can confirm the exact values).

Who may not be able to join:

People who are not considered suitable candidates for chemotherapy or targeted therapy treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8657189713716

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06658080

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: +8657189713716

More information: https://clinicaltrials.gov/study/NCT06658080

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have given written agreement to take part in the study and are willing to participate.
People who are between 18 and 70 years old.
People who have been diagnosed with breast cancer that has spread (metastatic), and who also have fluid build-up in the chest or abdomen that has been confirmed by a lab test to contain cancer cells.
People who are generally well enough to carry out daily activities, based on a standard health scoring system (a score of 0 or 1 on the ECOG scale — confirm with trial site if unsure what this means).
People whose liver and kidney function blood test results are within an acceptable range, meaning no significant problems with these organs (specific blood marker levels must meet set limits — the trial site can confirm the exact values).

Who may not be able to join:

People who are not considered suitable candidates for chemotherapy or targeted therapy treatment.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

9 November 2024

Est. completion

25 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Correlation between drug sensitivity test results in patient-derived organoid models and clinical outcomes. The drug sensitivity test results obtained from patient-derived organoid models will be compared with the clinical outcomes.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov